| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
|
|
L | | IP | CI | | Fluvastatin-Mepha 80 retard | 28 Tablet(s) | 14.71 | 29.20 | 10 % | | Delayed release tablets: Fluvastatinum 80 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
L | | IP | CI | | Fluvastatin-Mepha 80 retard | 98 Tablet(s) | 51.40 | 75.50 | 10 % | | Delayed release tablets: Fluvastatinum 80 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | IP | CI | A | Oxycodon Sandoz 5 | 30 Tablet(s) | 7.46 | 16.80 | 10 % | | Delayed release tablets: Oxycodoni Hydrochloridum 5 mg | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | |
| | IP | CI | A | Oxycodon Sandoz 5 | 60 Tablet(s) | 13.14 | 27.40 | 10 % | | Delayed release tablets: Oxycodoni Hydrochloridum 5 mg | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | |
| | IP | CI | A | Oxycodon Sandoz 10 | 30 Tablet(s) | 10.16 | 19.90 | 10 % | | Delayed release tablets: Oxycodoni Hydrochloridum 10 mg | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | |
| | IP | CI | A | Oxycodon Sandoz 10 | 60 Tablet(s) | 17.88 | 36.95 | 10 % | | Delayed release tablets: Oxycodoni Hydrochloridum 10 mg | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | |
| | IP | CI | A | Oxycodon Sandoz 20 | 30 Tablet(s) | 17.15 | 36.10 | 10 % | | Delayed release tablets: Oxycodoni Hydrochloridum 20 mg | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | |
| | IP | CI | A | Oxycodon Sandoz 20 | 60 Tablet(s) | 32.79 | 54.10 | 10 % | | Delayed release tablets: Oxycodoni Hydrochloridum 20 mg | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | |
| | IP | CI | | Oxycodon Sandoz 40 | 30 Tablet(s) | 35.57 | 57.30 | 10 % | | Delayed release tablets: Oxycodoni Hydrochloridum 40 mg | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | |
| | IP | CI | | Oxycodon Sandoz 40 | 60 Tablet(s) | 68.72 | 95.40 | 10 % | | Delayed release tablets: Oxycodoni Hydrochloridum 40 mg | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | |
| | IP | CI | | Oxycodon Sandoz 80 | 30 Tablet(s) | 62.41 | 88.15 | 10 % | | Delayed release tablets: Oxycodoni Hydrochloridum 80 mg | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | |
| | IP | CI | | Oxycodon Sandoz 80 | 60 Tablet(s) | 124.72 | 159.75 | 10 % | | Delayed release tablets: Oxycodoni Hydrochloridum 80 mg | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 2,5 | 28 Tablet(s) | 19.47 | 38.80 | 10 % | | Coated tablets: Olanzapinum 2.5 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 2,5 | 2 x 49 | 56.90 | 81.80 | 10 % | | Coated tablets: Olanzapinum 2.5 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 5 | 28 Tablet(s) | 32.70 | 54.00 | 10 % | | Coated tablets: Olanzapinum 5 mg | Sandoz Pharmaceuticals AG | ● B / SL / SG | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 5 | 2 x 49 | 95.57 | 126.25 | 10 % | | Coated tablets: Olanzapinum 5 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 10 | 28 Tablet(s) | 56.28 | 81.10 | 10 % | | Coated tablets: Olanzapinum 10 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 10 | 2 x 49 | 164.48 | 205.40 | 10 % | | Coated tablets: Olanzapinum 10 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 15 | 28 Tablet(s) | 81.95 | 110.60 | 10 % | | Coated tablets: Olanzapinum 15 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 15 | 2 x 49 | 239.50 | 291.65 | 10 % | | Coated tablets: Olanzapinum 15 mg | Sandoz Pharmaceuticals AG | ● B / SL / SG | FB | | G | |
| | IP | CI | | Fluoxetin Spirig HC | 30 Capsule(s) | 10.95 | 20.80 | 10 % | | Capsules: Fluoxetinum 20 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | IP | CI | | Fluoxetin Spirig HC | 100 Capsule(s) | 34.02 | 55.50 | 10 % | | Capsules: Fluoxetinum 20 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | IP | CI | | Nebivolol-Mepha 5 | 28 Tablet(s) | 5.23 | 14.20 | 10 % | | Tablets: Nebivololum 5 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | IP | CI | | Nebivolol-Mepha 5 | 56 Tablet(s) | 8.58 | 18.05 | 10 % | | Tablets: Nebivololum 5 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | IP | CI | | Nebivolol-Mepha 5 | 98 Tablet(s) | 14.20 | 28.65 | 10 % | | Tablets: Nebivololum 5 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 20 mg | 15 | 4.16 | 8.90 | 10 % | | magensaftresistente Filmtabletten: Pantoprazolum 20 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 20 mg | 30 | 8.08 | 17.50 | 10 % | | magensaftresistente Filmtabletten: Pantoprazolum 20 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 20 mg | 60 | 13.36 | 27.65 | 10 % | | magensaftresistente Filmtabletten: Pantoprazolum 20 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 20 mg | 120 | 24.93 | 45.05 | 10 % | | magensaftresistente Filmtabletten: Pantoprazolum 20 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 40 mg | 15 | 6.79 | 16.00 | 10 % | | magensaftresistente Filmtabletten: Pantoprazolum 40 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 40 mg | 30 | 12.86 | 27.10 | 10 % | | magensaftresistente Filmtabletten: Pantoprazolum 40 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 40 mg | 60 | 21.23 | 40.80 | 10 % | | magensaftresistente Filmtabletten: Pantoprazolum 40 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 40 mg | 100 | 33.51 | 54.90 | 10 % | | magensaftresistente Filmtabletten: Pantoprazolum 40 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 40 mg | 120 | 40.21 | 62.60 | 10 % | | magensaftresistente Filmtabletten: Pantoprazolum 40 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | IP | CI | | Dexagenta-POS | 5 ml | 2.91 | 7.45 | 10 % | | Eye drops: 2 Active Agents | URSAPHARM Schweiz GmbH | A / SL | FB | | G | |
L | | IP | CI | | Enbrel MyClic 50 mg | 2 | 409.59 | 487.10 | 10 % | | Injektionslösung im Fertigpen: Etanerceptum 50 mg/ml | Pfizer AG | B / SL | FB | | G | |
| | IP | CI | PP | Onbrez Breezhaler 150 mcg | 30 Capsule(s) | 35.06 | 56.70 | 10 % | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | | G | |
| | IP | CI | PP | Onbrez Breezhaler 300 mcg | 30 Capsule(s) | 41.12 | 63.65 | 10 % | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | | G | |
| | IP | CI | PP | Onbrez Breezhaler 150 mcg | 90 Capsule(s) | 89.40 | 119.15 | 10 % | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | | G | |
| | IP | CI | PP | Onbrez Breezhaler 300 mcg | 90 Capsule(s) | 104.88 | 136.95 | 10 % | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | | G | |
| | IP | | | Natriumfluorid (18F) ZRP | ampoule(s) | PR | PR | k.A. | | Injection solution: Natrii Fluoridum(18-f) 0.02-8 G/ml | Universitätsspital Zürich | A | FB | | G | |
| | IP | | V/S | IXIARO | syringe(s) | PR | PR | k.A. | | Injection suspension: Enzephalitidis Japanensis viri Antigenum (Stamm: Sa-14-2) 6U. / 0.5ml | Bavarian Nordic Switzerland AG | ● B | FB | | G | |
| | IP | CI | | Bisolvon Ambroxol 1x TÄGLICH | 10 | PR | PR | k.A. | | Delayed release capsules: Ambroxoli Hydrochloridum 75 mg | Opella Healthcare Switzerland AG | D | FB | | G | |
| | IP | CI | | Mycoster | 30 g | PR | PR | k.A. | | Cream: Ciclopiroxum Olaminum 10 mg | Pierre Fabre Pharma SA | B | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 2,5 | 98 Tablet(s) | 56.90 | 81.70 | k.A. | | Coated tablets: Olanzapinum 2.5 mg | Sandoz Pharmaceuticals AG | B | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 5 | 98 Tablet(s) | 95.57 | 126.10 | k.A. | | Coated tablets: Olanzapinum 5 mg | Sandoz Pharmaceuticals AG | B | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 10 | 98 Tablet(s) | 164.48 | 205.20 | k.A. | | Coated tablets: Olanzapinum 10 mg | Sandoz Pharmaceuticals AG | B | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 15 | 98 Tablet(s) | 239.50 | 291.35 | k.A. | | Coated tablets: Olanzapinum 15 mg | Sandoz Pharmaceuticals AG | B | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 20 | 28 Tablet(s) | PR | PR | k.A. | | Coated tablets: Olanzapinum 20 mg | Sandoz Pharmaceuticals AG | B | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 20 | 98 Tablet(s) | PR | PR | k.A. | | Coated tablets: Olanzapinum 20 mg | Sandoz Pharmaceuticals AG | B | FB | | G | |
| | IP | CI | | Olanzapin Sandoz 20 | 2 x 49 | PR | PR | k.A. | | Coated tablets: Olanzapinum 20 mg | Sandoz Pharmaceuticals AG | B | FB | | G | |
| | | CI | Ph | Vita Prostata uno | 30 | PR | PR | k.A. | | Coated tablets: Urticae Radicis Extractum Methanolicum Siccum (Urtica Dioica l., Urtica Urens l., Radix) 600 mg | Doetsch Grether AG | D | FB | | G | |
| | | CI | Ph | Vita Prostata uno | 100 | PR | PR | k.A. | | Coated tablets: Urticae Radicis Extractum Methanolicum Siccum (Urtica Dioica l., Urtica Urens l., Radix) 600 mg | Doetsch Grether AG | D | FB | | G | |
| | | CI | Ph | Vitango | 30 | PR | PR | k.A. | | Coated tablets: Rhodiolae Radicis et Rhizomae Extractum Ethanolicum Siccum (Rhodiola Rosea l., Radix et Rhizoma) 200 mg | Schwabe Pharma AG | D / LPPV | FB | | G | |
| | | CI | Ph | Vitango | 60 | PR | PR | k.A. | | Coated tablets: Rhodiolae Radicis et Rhizomae Extractum Ethanolicum Siccum (Rhodiola Rosea l., Radix et Rhizoma) 200 mg | Schwabe Pharma AG | D / LPPV | FB | | G | |
| | | CI | Ph | Vitango | 90 | PR | PR | k.A. | | Coated tablets: Rhodiolae Radicis et Rhizomae Extractum Ethanolicum Siccum (Rhodiola Rosea l., Radix et Rhizoma) 200 mg | Schwabe Pharma AG | D / LPPV | FB | | G | |
| | IP | CI | PP | Onbrez Breezhaler 150 mcg | 90 Capsule(s) | PR | PR | k.A. | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents | Novartis Pharma Schweiz AG | B | FB | | G | |
| | IP | CI | PP | Onbrez Breezhaler 300 mcg | 90 Capsule(s) | PR | PR | k.A. | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents | Novartis Pharma Schweiz AG | B | FB | | G | |
| | | CI | H | CERES Taraxacum comp. Leber-Galle Tropfen | 20 ml | PR | PR | k.A. | | Tropfen zum Einnehmen: 3 Active Agents | Ceres Heilmittel AG | D | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 20 mg | 15 | PR | PR | k.A. | | magensaftresistente Filmtabletten: Pantoprazolum 20 mg | Mepha Pharma AG | B | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 20 mg | 30 | PR | PR | k.A. | | magensaftresistente Filmtabletten: Pantoprazolum 20 mg | Mepha Pharma AG | B | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 20 mg | 60 | PR | PR | k.A. | | magensaftresistente Filmtabletten: Pantoprazolum 20 mg | Mepha Pharma AG | B | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 20 mg | 120 | PR | PR | k.A. | | magensaftresistente Filmtabletten: Pantoprazolum 20 mg | Mepha Pharma AG | B | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 40 mg | 7 | PR | PR | k.A. | | magensaftresistente Filmtabletten: Pantoprazolum 40 mg | Mepha Pharma AG | B | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 40 mg | 15 | PR | PR | k.A. | | magensaftresistente Filmtabletten: Pantoprazolum 40 mg | Mepha Pharma AG | B | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 40 mg | 30 | PR | PR | k.A. | | magensaftresistente Filmtabletten: Pantoprazolum 40 mg | Mepha Pharma AG | B | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 40 mg | 60 | PR | PR | k.A. | | magensaftresistente Filmtabletten: Pantoprazolum 40 mg | Mepha Pharma AG | B | FB | | G | |
| | IP | CI | | Pantoprazol-Mepha Teva 40 mg | 100 | PR | PR | k.A. | | magensaftresistente Filmtabletten: Pantoprazolum 40 mg | Mepha Pharma AG | B | FB | | G | |